The JCSR Foundation’s mission and Jibraan’s story featured in Global Health Resilience, a Mediaplanet supplement distributed with The Guardian on 18 June 2026.
The article, “AMR and sepsis: The hidden crisis for cancer care”, brings together insights from our founder and chairperson, Dr Nveed Chaudhary, and Antonella Cardone, CEO of Cancer Patients Europe. Highlighting a vital concern: advances in cancer treatment must be matched by better protection against infection and sepsis.
For patients whose immune systems have been weakened by treatment, infections can rapidly become life-threatening. Antimicrobial resistance (AMR) makes these infections harder to treat, putting patients at further risk and potentially interrupting essential cancer care.
The feature shares Jibraan’s experience of developing sepsis while undergoing chemotherapy for leukaemia, and how his loss inspired the Foundation’s commitment to research.
“The resilience of cancer care depends on recognising infection and sepsis much earlier in the treatment pathway,” explains Dr Chaudhary.
The article calls for stronger infection prevention, faster diagnosis, appropriate antimicrobial use and prompt action when patients deteriorate. It also stresses the importance of giving patients and families clear, accessible information about infection risks during treatment.
For us, this coverage is an opportunity to bring an often-overlooked aspect of cancer care to a wider audience. Jibraan’s legacy continues to guide our work: supporting research and raising awareness to help protect other patients and families from the devastating impact of sepsis.
Read the full Global Health Resilience supplement.
Key Takeaways
Advances in cancer treatment must be matched by better protection against infection and sepsis.
Infections can rapidly become life-threatening for patients with weakened immune systems.
Antimicrobial resistance (AMR) makes infections harder to treat.
The resilience of cancer care depends on recognising infection and sepsis much earlier in the treatment.